Sign inJoin waitlistJoin the waitlist

Robert D. McBane

Director, Vascular Medicine Clinic, Division of Vascular, Department of Cardiovascular Medicine · Mayo Clinic

Credentials: · · ·

History

Mayo Clinic
Present

Research

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
New England Journal of Medicine · 2019 · 567 citations
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Journal of Thrombosis and Haemostasis · 2020 · First of 17 authors · 435 citations
The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients
Circulation · 2012 · 397 citations

Waldemar Wysokinski
120 papers
Damon Houghton
58 papers · 23 as a fellow
Ana Casanegra
45 papers
Paul Wennberg
21 papers
Thom Rooke
19 papers
AT
Alfonso Tafur
17 papers · 4 as a fellow
Aneel Ashrani
15 papers
JH
John Heit
15 papers
PD
Paul Daniels
15 papers
David Froehling
13 papers
Harald Bjarnason
13 papers
Rajiv Pruthi
13 papers

Clinical trials

Calf Deep Vein Thrombosis Treatment Trial
Principal investigator · Terminated · Phase 4
Mayo Clinic
2019
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Principal investigator · Completed · Phase 3
Academic and Community Cancer Research United
2017–2025
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Principal investigator · Completed · Phase 3
Academic and Community Cancer Research United
2015–2019